Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Interaction between digoxin and dronedarone in the PALLAS trial.

Hohnloser SH, Halperin JL, Camm AJ, Gao P, Radzik D, Connolly SJ; PALLAS investigators.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1019-25. doi: 10.1161/CIRCEP.114.002046. Epub 2014 Nov 6.

2.

Combined electrical and global markers of dyssynchrony predict clinical response to cardiac resynchronization therapy.

Bajraktari G, Rönn F, Ibrahimi P, Jashari F, Lindmark K, Jensen SM, Henein MY.

Scand Cardiovasc J. 2014 Oct;48(5):304-10. doi: 10.3109/14017431.2014.950601. Epub 2014 Sep 2.

PMID:
25117854
3.

Edoxaban versus warfarin in patients with atrial fibrillation.

Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators.

N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19.

4.

U22 protocol as measure of symptomatic improvement after catheter ablation of atrial fibrillation.

Höglund N, Rönn F, Tollefsen T, Jensen SM, Kesek M.

Ups J Med Sci. 2013 Nov;118(4):240-6. doi: 10.3109/03009734.2013.821190.

5.

Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.

Kowey PR, Crijns HJ, Aliot EM, Capucci A, Kulakowski P, Radzik D, Roy D, Connolly SJ, Hohnloser SH; ALPHEE Study Investigators.

Circulation. 2011 Dec 13;124(24):2649-60. doi: 10.1161/CIRCULATIONAHA.111.072561. Epub 2011 Nov 14.

6.

Dronedarone in high-risk permanent atrial fibrillation.

Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum Á, Blomström P, Borggrefe M, Budaj A, Chen SA, Ching CK, Commerford P, Dans A, Davy JM, Delacrétaz E, Di Pasquale G, Diaz R, Dorian P, Flaker G, Golitsyn S, Gonzalez-Hermosillo A, Granger CB, Heidbüchel H, Kautzner J, Kim JS, Lanas F, Lewis BS, Merino JL, Morillo C, Murin J, Narasimhan C, Paolasso E, Parkhomenko A, Peters NS, Sim KH, Stiles MK, Tanomsup S, Toivonen L, Tomcsányi J, Torp-Pedersen C, Tse HF, Vardas P, Vinereanu D, Xavier D, Zhu J, Zhu JR, Baret-Cormel L, Weinling E, Staiger C, Yusuf S, Chrolavicius S, Afzal R, Hohnloser SH; PALLAS Investigators.

N Engl J Med. 2011 Dec 15;365(24):2268-76. doi: 10.1056/NEJMoa1109867. Epub 2011 Nov 14. Erratum in: N Engl J Med. 2012 Feb 16;366(7):672.

7.

Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.

Rönn F, Kesek M, Karp K, Henein M, Jensen SM.

Europace. 2011 Dec;13(12):1747-52. doi: 10.1093/europace/eur193. Epub 2011 Jun 28.

PMID:
21712261
8.

Symptomatic improvement after catheter ablation of supraventricular tachycardia measured by the arrhythmia-specific questionnaire U22.

Kesek M, Rönn F, Tollefsen T, Höglund N, Näslund U, Jensen SM.

Ups J Med Sci. 2011 Mar;116(1):52-9. doi: 10.3109/03009734.2010.517875. Epub 2010 Nov 16.

9.

Dabigatran versus warfarin in patients with atrial fibrillation.

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators.

N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30. Erratum in: N Engl J Med. 2010 Nov 4;363(19):1877.

10.

U22, a protocol to quantify symptoms associated with supraventricular tachycardia.

Kesek M, Tollefsen T, Höglund N, Rönn F, Näslund U, Jensen SM.

Pacing Clin Electrophysiol. 2009 Mar;32 Suppl 1:S105-8. doi: 10.1111/j.1540-8159.2008.02263.x.

PMID:
19250069
11.

Long-term follow-up of patients treated with ICD: benefit in patients with preserved left ventricular function.

Rönn F, Kesek M, Höglund N, Jensen SM.

Scand Cardiovasc J. 2008 Apr;42(2):125-9. doi: 10.1080/14017430701762719.

PMID:
18365895
12.

Reduction of fluoroscopy duration in radiofrequency ablation obtained by the use of a non-fluoroscopic catheter navigation system.

Kesek M, Wallenius N, Rönn F, Höglund N, Jensen S.

Europace. 2006 Dec;8(12):1027-30. Epub 2006 Nov 13.

PMID:
17101627
13.

[Experiment with small compressed-air apparatus and powder for treatment of persons and clothing with DDT powder].

RONN F, LUNDH NR.

Tidskr Mil Halsov. 1955;80(2-3):65-83. Swedish. No abstract available.

PMID:
13311868

Supplemental Content

Loading ...
Support Center